Stony Brook University Logo and Title
Photo: Stony Brook banners in front of trees
News Page Title Bar
 Top News
 General University News
 SB Medicine News
 Children's Hospital
 Faculty/Student Awards
 Conferences & Events
 Media Advisories
 Press Clips
 Student Media Briefings

SB Medicine News
Press Release

SBU Heart Institute's VAD Program Earns Reaccreditation

Mar 7, 2013 - 10:58:45 AM

Email this article
 Printer friendly page
Members of the Stony Brook University Heart Institute’s Ventricular Assist Device (VAD) team include, left to right: Hal Skopicki, MD, PhD, FACC, FAHA, FACP, Co-Director of the VAD Program; Alison McLarty, MD, FACS, Surgical Co-Director of the VAD program; Ellen McCarty-Santoro, MSN, CANP, Nurse Practitioner with the Heart Failure Program; Kathleen Lopez-Newton, MSN, NP, VAD Coordinator; James R. Taylor Jr., MD, FACS, Co-Director of the Stony Brook University Heart Institute; Kathryn Scheriff, RN, MSN, CNOR, Interim Associate Director of Nursing for the Heart Institute; Fola Akande, BSN, CNS, FNP-C, Nurse Practitioner with the Heart Failure Program; and Michelle Bloom, MD, FACC, Director of Outpatient Services for the Heart Failure Program.
, February 27, 2013 – Stony Brook University Heart Institute’s Ventricular Assist Device (VAD) program has earned reaccreditation from The Joint Commission after an intensive two-day review. The two-year reaccreditation extends from Jan. 31, 2013, through Jan. 31, 2015.

Stony Brook was the first hospital on Long Island to implant a HeartMate II VAD device in 2010 and became the first accredited VAD program on Long Island in 2011. To date, 20 patients have received VADs, which are surgically implanted, electrically (battery) powered pumps that helps a failing heart's left ventricle pump adequate amounts of blood to the body.

“Accreditation signifies that our program provides safe, high-quality care for patients with heart failure,” said Kenneth Kaushansky, MD, Senior Vice President, Health Sciences, and Dean, Stony Brook University School of Medicine. “It is a seal of approval that signals to patients that they are in capable hands when they come to Stony Brook Medicine.”

VAD is considered “destination therapy” as the final treatment option for select patients whose hearts require mechanical assistance to pump blood. It is also used as a bridge to heart transplantation in patients with heart failure or other incurable heart conditions.

“This achievement demonstrates the high quality of care we deliver to our patients and our expertise at providing the highest levels of care for patients with advanced heart failure,” said Reuven Pasternak, MD, Chief Executive Officer, Stony Brook University Hospital, and Vice President for Health Systems, Stony Brook Medicine.

“Accreditation confirms our Heart team’s superb clinical practice,” said Alison McLarty, MD, Surgical Co-Director of the VAD program. “The Joint Commission singled out Stony Brook for its care and commitment to advanced cardiac heart failure patients and for maintaining the highest standards of care… The surveyor was thoroughly impressed with the level of knowledge our nurses and operating room team demonstrated.”

Hal Skopicki, MD, PhD, FACC, FAHA, FACP, Director of the Heart Failure and Cardiomyopathy Program at Stony Brook University Hospital and Co-Director of the VAD Program, said the success of Stony Brook’s VAD program is the result of a joint effort by a large network of cardiologists on Long Island, combined with Stony Brook’s multidisciplinary treatment team – including gastroenterologists, pulmonologists, nephrologists, infectious disease specialists, psychiatrists and hematology/oncologists. “Together, we marshal our efforts to create excellent outcomes for our patients,” he said.

“Our successful review by The Joint Commission reflects a total team commitment to providing quality care to patients requiring ventricular assist devices,” said Margaret Duffy, MS, RN, NEA-BC, Interim Chief Nursing Officer and Associate Director of Nursing for Cardiac Services at Stony Brook University Hospital.

VAD Coordinator Kathleen Lopez-Newton, NP, provides surgical and medical management of patients to allow for their intricate care. “Watching patients transform from end-stage heart failure patients with severe breathing challenges and limited energy levels to vibrant, interactive members of their communities is the greatest reward you can imagine in medicine” Lopez-Newton said. “To be part of their journey from sickness to active family members, parents, grandparents, sisters and brothers…it is truly amazing.”

To achieve accreditation, VAD programs are evaluated on standards in The Joint Commission's Disease-Specific Care Certification Manual. Programs must demonstrate conformity with clinical practice guidelines or evidence-based practices. They are also required to collect and analyze data on at least four performance measures related to clinical practice guidelines until more standardized performance measures are identified.

Accredited programs must also:

•    Provide VAD destination therapy to an adult population
•    Have facilities with the infrastructure to support VAD placement, including adequate staffing and facilities to perform and recover patients after cardiac surgery
•    Be an active continuous member of a national, audited registry for mechanically assisted circulatory support devices that requires submission of health data on ventricular assist device destination therapy patients from the date of implantation throughout the remainder of their lives
•    Include a board-certified cardiac surgeon has placed 10 VADs in the past 36 months with current activity in the past 12 months.


About Stony Brook University Heart Institute:
Stony Brook University Heart Institute is located within Stony Brook University Hospital as part of Long Island's premier university-based medical center. The Heart Institute offers a comprehensive, multidisciplinary program for the prevention, diagnosis and treatment of cardiovascular disease. The staff includes 50 full-time and community-based, board-certified cardiologists and cardiothoracic surgeons, as well as 350 specially trained anesthesiologists, nurses, physician assistants, nurse practitioners, respiratory therapists, surgical technologists, perfusionists, and other support staff. Their combined expertise provides state-of-the-art interventional and surgical capabilities in 24-hour cardiac catheterization labs and surgical suites. And while the Heart Institute clinical staff offers the latest advances in medicine, its physician-scientists are also actively enhancing knowledge of the heart and blood vessels through basic biomedical studies and clinical research. To learn more, visit

About The Joint Commission:
Founded in 1951, The Joint Commission seeks to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations and inspiring them to excel in providing safe and effective care of the highest quality and value. The Joint Commission evaluates and accredits more than 20,000 health care organizations and programs in the United States, including more than 10,600 hospitals and home care organizations, and more than 6,600 other health care organizations that provide long term care, behavioral health care, laboratory and ambulatory care services. The Joint Commission also certifies more than 2,400 disease-specific care programs such as stroke, heart failure, joint replacement and stroke rehabilitation, and 400 health care staffing services. An independent, not-for-profit organization, The Joint Commission is the nation's oldest and largest standards-setting and accrediting body in health care. Learn more about The Joint Commission at

© Stony Brook University 2013

Top of Page